search
Back to results

Impact of Placement of a Diazepam Suppository on Early Postoperative Pain Following Pelvic Reconstructive Surgery

Primary Purpose

Postoperative Pain

Status
Unknown status
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Diazepam
Placebos
Sponsored by
TriHealth Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Postoperative Pain

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • English speaking, able to understand informed consent and questionnaires
  • Vaginal hysterectomy with vaginal vault suspension by one of the providers in the Division of Urogynecology and Reconstructive Pelvic Surgery at TriHealth, Inc.

    • With or without anterior and posterior repairs
    • With or without concomitant procedure for stress urinary incontinence
    • With or without removal of fallopian tubes or ovaries

Exclusion Criteria:

  • Use of mesh for prolapse repair
  • Robotic, laparoscopic, or open technique used for prolapse repair and/or hysterectomy
  • Concomitant procedure done by an additional surgeon
  • Concomitant anal sphincteroplasty or rectovaginal fistula repair
  • Contraindication to use of Diazepam:

    • Allergy to Diazepam or other benzodiazepines
    • Acute narrow-angle glaucoma
    • Untreated open-angle glaucoma
    • Myasthenia gravis
    • Severe respiratory impairment
    • Severe hepatic impairment
  • History of chronic pelvic pain receiving medical care
  • Daily use of medication for pain: NSAID, Tylenol, opioid, gabapentin, and/or amitriptyline
  • Pregnancy

Sites / Locations

  • Trihealth (Good Samaritan Hospital, Bethesda North Hospital)Recruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Diazepam group

Placebo group

Arm Description

Rectal Diazepam suppository

Placebo suppository

Outcomes

Primary Outcome Measures

Vaginal/Rectal pain in Visual Analogue Scale (VAS) score
VAS is a validated 100 millimeter scale with no pain as 0 mm and worst pain as 100 mm. Subjects draw a vertical line on the scale corresponding to their pain level.

Secondary Outcome Measures

Full Information

First Posted
December 11, 2019
Last Updated
July 21, 2020
Sponsor
TriHealth Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT04198233
Brief Title
Impact of Placement of a Diazepam Suppository on Early Postoperative Pain Following Pelvic Reconstructive Surgery
Official Title
Impact of Placement of a Diazepam Suppository Intraoperatively on Early Postoperative Pain Following Pelvic Reconstructive Surgery: a Double-Blind, Randomized Placebo-Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
February 12, 2020 (Actual)
Primary Completion Date
May 2022 (Anticipated)
Study Completion Date
December 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
TriHealth Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a randomized double-blinded placebo controlled trial to examine the use of rectal diazepam suppositories after major vaginal pelvic organ prolapse surgery will decrease postoperative pain in the interval between 3.5 and 6 hours postoperative compared to placebo.
Detailed Description
Hysterectomy is the most common major surgery performed in gynecology. Minimally invasive techniques for hysterectomy including vaginal and laparoscopic routes are preferred over the more invasive abdominal procedures, which are associated with more pain, longer hospital stays, and increased rates of complications. Research has continued to provide evidence that same day discharge (SDD) after hysterectomy is safe, cost effective, and well received by patients. Pain is a common concern for patients undergoing major pelvic surgery and pain must be well controlled prior to discharge home. Rectal administrations of medications are an attractive option postoperatively in patients desiring SDD. Rectal analgesia avoids 1st pass metabolism in the liver, leading to increased bioavailability of many medications and fewer side effects such as nausea and vomiting. The purpose of the study is to investigate whether perioperative administration of a rectally administered diazepam suppository results in improved pain scores between 3.5 and 6 hours postoperatively in patients undergoing major vaginal pelvic reconstructive surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Postoperative Pain

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Masking Description
All surgeons, patients and research staff will be blinded.
Allocation
Randomized
Enrollment
130 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Diazepam group
Arm Type
Experimental
Arm Description
Rectal Diazepam suppository
Arm Title
Placebo group
Arm Type
Placebo Comparator
Arm Description
Placebo suppository
Intervention Type
Drug
Intervention Name(s)
Diazepam
Intervention Description
Diazepam 10 mg compounded suppository
Intervention Type
Drug
Intervention Name(s)
Placebos
Intervention Description
Placebo suppository
Primary Outcome Measure Information:
Title
Vaginal/Rectal pain in Visual Analogue Scale (VAS) score
Description
VAS is a validated 100 millimeter scale with no pain as 0 mm and worst pain as 100 mm. Subjects draw a vertical line on the scale corresponding to their pain level.
Time Frame
between 3.5 and 6 hours postoperatively

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: English speaking, able to understand informed consent and questionnaires Vaginal hysterectomy with vaginal vault suspension by one of the providers in the Division of Urogynecology and Reconstructive Pelvic Surgery at TriHealth, Inc. With or without anterior and posterior repairs With or without concomitant procedure for stress urinary incontinence With or without removal of fallopian tubes or ovaries Exclusion Criteria: Use of mesh for prolapse repair Robotic, laparoscopic, or open technique used for prolapse repair and/or hysterectomy Concomitant procedure done by an additional surgeon Concomitant anal sphincteroplasty or rectovaginal fistula repair Contraindication to use of Diazepam: Allergy to Diazepam or other benzodiazepines Acute narrow-angle glaucoma Untreated open-angle glaucoma Myasthenia gravis Severe respiratory impairment Severe hepatic impairment History of chronic pelvic pain receiving medical care Daily use of medication for pain: NSAID, Tylenol, opioid, gabapentin, and/or amitriptyline Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eunsun Yook, MS
Phone
513-463-4300
Email
eunsun_yook@trihealth.com
First Name & Middle Initial & Last Name or Official Title & Degree
Emily Aldrich, MD
Phone
513-463-4300
Email
Emily_Aldrich@trihealth.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rachel Pauls, MD
Organizational Affiliation
TriHealth - Cincinnati Urogynecology Associates
Official's Role
Principal Investigator
Facility Information:
Facility Name
Trihealth (Good Samaritan Hospital, Bethesda North Hospital)
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45220
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emily Aldrich, MD
Email
Emily_Aldrich@trihealth.com
First Name & Middle Initial & Last Name & Degree
Rachedl Pauls, MD
Email
Rachel_Pauls@trihealth.com

12. IPD Sharing Statement

Citations:
PubMed Identifier
35550374
Citation
Aldrich ER, Tam TY, Saylor LM, Crisp CC, Yeung J, Pauls RN. Intrarectal diazepam following pelvic reconstructive surgery: a double-blind, randomized placebo-controlled trial. Am J Obstet Gynecol. 2022 Aug;227(2):302.e1-302.e9. doi: 10.1016/j.ajog.2022.05.009. Epub 2022 May 10.
Results Reference
derived

Learn more about this trial

Impact of Placement of a Diazepam Suppository on Early Postoperative Pain Following Pelvic Reconstructive Surgery

We'll reach out to this number within 24 hrs